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The folding catalyst protein disulfide isomerase is constructed of
active and inactive thioredoxin modules
Johan Kemmink*, Nigel J. Darby*, Klaas Dijkstra†, Michael Nilges* and Thomas
E. Creighton*
Background: Protein disulfide isomerase (PDI), a multifunctional protein of the
endoplasmic reticulum, catalyzes the formation, breakage and rearrangement of
disulfide bonds during protein folding. Dissection of this protein into its individual
domains has confirmed the presence of the a and a′ domains, which are
homologous to thioredoxin, having related structures and activities. The a and a′
domains both contain a –Cys–Gly–His–Cys– active-site sequence motif. The
remainder of the molecule consists primarily of two further domains, designated
b and b′, which are thought to be sequence repeats on the basis of a limited
sequence similarity. The functions of the b and b′ domains are unknown and,
until now, the structure of neither domain was known.
Results: Heteronuclear nuclear magnetic resonance (NMR) methods have been
used to detetermine the global fold of the PDI b domain. The protein has an a/b
fold with the order of the elements of secondary structure being
b1–a1–b2–a2–b3–a3–b4–b5–a4. The strands are all in a parallel
arrangement with respect to each other, except for b4 which is antiparallel. The
arrangement of the secondary structure elements of the b domain is identical to
that found in the a domain of PDI and in the ubiquitous redox protein thioredoxin;
the three-dimensional folding topology of the b domain is also very similar to that
of these proteins.
Conclusions: Our determination of the global fold of the b domain of PDI by
NMR reveals that, like the a domain, the b domain contains the thioredoxin motif,
even though the b domain has no significant amino-acid sequence similarities to
any members of the thioredoxin family. This observation, together with indications
that the b′ domain adopts a similar fold, suggests that PDI consists of active and
inactive thioredoxin modules. These modules may have been adapted during
evolution to provide PDI with its complete spectrum of enzymatic activities.
Background
Protein disulfide isomerase (PDI) was the first protein-
folding catalyst to be discovered [1,2] and appears to be
the primary catalyst of protein folding involving disulfide
bond formation in the eukaryotic endoplasmic reticulum
[3,4]. Although the function of PDI has been known for
more than thirty years, its structure has not been
determined; consequently, in contrast to other proteins
that assist protein folding, many aspects of the mechanism
of PDI action remain unknown. A major advance in the
understanding of the structure and disulfide isomerase
activities of PDI was the discovery by Edman et al. [5] that
the primary structure of PDI contains two segments that
are homologous both to each other (47% identity) and to
thioredoxin. The thioredoxin fold is incorporated into a
variety of proteins that catalyze the formation and
reduction of disulfide bonds in other substrate proteins
[6]. The active sites of these catalysts contain the motif
–Cys–X–Y-Cys–, which cycles between the dithiol and
disulfide forms during catalysis [7]. The disulfide bond of
thioredoxin is stable and thus stabilizes the folded
conformation of this protein [7,8]; however, the disulfide
bonds of PDI and other thioredoxin-related proteins are
unstable and destabilizing [9,10], as a result of differences
in interactions with the thiol groups of the reduced forms
[11]. Thus, thioredoxin reduces protein disulfide bonds,
whereas the other related proteins catalyze the formation
of these bonds [12].
Until now, the structure and functions of only the
thioredoxin-like a and a′ domains of PDI have been
clearly elucidated. The middle section of the PDI
sequence was interpreted by Edman et al. [5] to consist of
two segments that are homologous to each other (but only
28% identical in part of their sequences) and these were
termed the b and b′ domains. The domain structure of PDI
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(Fig. 1) has recently been determined experimentally by a
combination of protein engineering and limited proteolysis
studies [13]. This structure confirms the original domain
assignments of Edman et al. [5], although with different
domain limits (Fig. 1), and rules out subsequently reported
modifications [14]. The structure of the a domain has been
confirmed as resembling that of thioredoxin [15]. 
The a and a′ domains catalyze only a subset of the
reactions catalyzed by PDI, which in particular includes
those involved in forming protein disulfide bonds [16].
These domains are inefficient in the catalysis of disulfide
rearrangements, especially in folding intermediates that
contain substantial amounts of folded structure; their
isomerase activity is dependent upon the presence of the b
and b′ domains. Establishing the structures of the b and b′
domains is therefore an important step in understanding
their functional contribution to the complete PDI
molecule.
Results and discussion
PDI b-domain folding topology
The global fold of the b domain has now been
determined using multi-dimensional nuclear magnetic
resonance (NMR) techniques. The protein studied
consisted of residues 119–228 of mature human PDI
[13], and gave NMR spectra characteristic of a folded
protein (Fig. 2). Assignments were accomplished using
[15N]- and [15N plus 13C]-labelled forms. The patterns of
secondary structure present in the b domain were
determined initially from chemical shift and nuclear
Overhauser effect (NOE) data, which showed that the
order of a helices and b strands in the sequence is
b1–a1–b2–a2–b3–a3–b4–b5–a4. Backbone NOE patterns
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Figure 1
The domain structure of human PDI. The
domain boundaries have been determined by a
combination of protein engineering and limited
proteolysis studies ([13] and unpublished
observations). The first and last residues of
each folded structure are indicated. The c
domain at the carboxyl terminus comprises a 24
residue acidic segment in which over half the
residues are glutamate or aspartate, followed
by the KDEL (Lys–Asp–Glu–Leu) sequence for
retention in the endoplasmic reticulum.
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Figure 2
The 1H–15N heteronuclear single quantum
coherence (HSQC) spectrum of 13C/15N-
enriched PDI b domain. Residue-specific
assignments of backbone 1H and 15N
frequencies are indicated. The horizontal lines
connect peaks originating from asparagine
and glutamine side-chain NH2 groups. The
two peaks marked with x originate from partial
degradation of the sample at the
(unstructured) carboxyl terminus, involving
residues Gln226–Ala228.
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between HN and Ha atoms gave the topology of the five-
stranded b sheet, b1–b3–b2–b4–b5, in which only b4 is
antiparallel to the others. The three-dimensional fold of
the backbone of the b domain was determined using 925
NMR restraints. A superposition of the backbones of the
10 structures with the lowest total energy of the
ensemble of 20 structures calculated is shown in Figure
3. Residues 120–217 were found in fixed, folded
conformations, in agreement with the limits of the folded
structure inferred from protection against limited
proteolysis [13].
Similarities with other structures
The structure of the b domain is very similar to that of
thioredoxin and of other members of the family of
thioredoxin-related proteins, including the PDI a domain
(Fig. 4) [15]. Automated comparison of the b-domain
structure with others in the protein structure database
revealed that the structure was primarily similar to pro-
teins containing the thioredoxin motif. The root mean
square (r.m.s.) differences between the structures of
human thioredoxin and of the a and b domains were 2.1 Å
and 2.2 Å, respectively; the a and b domains were less
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Figure 3
Stereoview of the Ca traces of the 10
structures used for analysis of the b domain
generated from the NMR data. The 10
carboxy-terminal residues were disordered,
and therefore only residues 119–218 are
plotted. The structures were superimposed
with respect to the backbone N, Ca and C′
atoms in the ensemble [40].
Figure 4
MOLSCRIPT representations [41] of one of
the structures of (a) the PDI a domain and of
(b) the b domain (right) in the same
orientation. The active-site disulfide bond of
the a domain is depicted at the lower right as
a ball-and-stick model.
(a) (b)
similar to each other, with an r.m.s. difference of 3.5 Å.
Alignments of the primary structures of the a and b
domains with human thioredoxin, based on their three-
dimensional structures, are presented in Figure 5.
The close similarity of the three-dimensional structure of
the PDI b domain to that of thioredoxin is surprising, as
their primary structures are not detectably similar and no
sequence homology has been reported previously. Align-
ment of the sequences of thioredoxin and the PDI a and b
domains on the basis of their common structures (Fig. 5)
also produces only minimal similarities. In terms of
primary sequence, only four positions have the same
amino-acid residue in all three sequences (Fig. 5). Of the
110 residues of the b domain, only 17 are identical to
human thioredoxin; in contrast, 30 are identical between
thioredoxin and the PDI a domain. Nevertheless, the
analysis of the primary structure of the b domain, using the
procedure ‘gonnet+predss’ [17] (available at URL
http://www.mbi.ucla.edu/people/frsvr/frsvr.html), identi-
fied the thioredoxin fold as being the most likely structure
adopted by this domain.
Edman et al. [5] concluded that the segments corresponding
approximately to the b and b′ domains were sufficiently
similar in amino-acid sequence and secondary- structure
propensities to allow one to conclude that they are homolo-
gous. These similarities are not totally convincing in them-
selves, but analysis of the b′ domain by the ‘gonnet+predss’
procedure also indicated that this domain is most likely to
adopt the thioredoxin fold; this assignment is consistent
with the spectral and physical properties of the b′ domain
(our unpublished observations).
Modular structure of PDI
The finding that the individual a, a′, b and b′ domains of
PDI have folded structures that are stable in isolation indi-
cates that PDI has a modular structure [18]. Moreover, the
stabilities of these modules appear to be similar whether
the modules are in isolation or found within the intact PDI
molecule [13], demonstrating that these relatively indepen-
dent modules share few stabilizing interactions in the intact
PDI molecule.
It is therefore likely that all four of the PDI modules arose
by partial gene duplication or shuffling of a common
thioredoxin ancestral gene, followed by divergence [18].
The absence of detectable amino-acid sequence similari-
ties in the b and b′ modules, in contrast to a and a′, presum-
ably is a result of both the length of time since the gene
duplication event and greater evolutionary pressures for
change; the b and b′ modules have changed more rapidly
than a and a′ amongst the known PDI sequences. All four
modules probably arose before the appearance of most
eukaryotic species, because homologous PDI sequences
are present in eukaryotes as diverse as mammals, yeast and
plants. All of these eukaryotic PDIs have recognizable a
and a′ modules [19]; the putative b and b′ modules have
diverged so much between species that it is not certain
that they are all homologous, but the corresponding seg-
ments always contain approximately the same number of
amino acids. 
There are recognizable a, a′ and b sequences in the
ERp60 and ERp72 homologues of PDI [20,21], suggesting
that they arose from the same ancestor as PDI; in the case
of ERp72, a further gene-shuffling event has added
another thioredoxin-like module to the amino terminus
[21]. Thus, PDI demonstrates that modular proteins arose
in the distant past, in contrast to the common belief that
such modular evolution is a recent phenomenon. Adjacent
homologous modules might tend to be more apparent in
recently diverged proteins if the modules merge
structurally to become a single module during evolution-
ary divergence. PDI might be an exception to this propo-
sition because its modular structure has been retained
during evolution. 
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Figure 5
Sequence alignments of the human PDI a and b domains and of
thioredoxin (hTRX), based on their structures. The alignments were
made using the program DALI [42] and the FSSP database [43]. The
aligned residues occur in the same spatial positions in the structures; a
dash indicates that there was no homologous residue. The numbers
above the sequences correspond to the numbering of the amino acids
in the PDI b domain. The four residues that are identical in all three
sequences are indicated with asterisks. The residues present in b
strands are red and those in a helices are blue. The –Cys–X–Y–Cys–
active site of hTRX and of the PDI a domain is boxed.
                120       130         140      
                                         *
hPDI  b  -------AATTLPDGAAAESLVESSE--VAVIGFFK
hTRX    -------MVKQIESKTAFQEALDAAGDKLVVVDFSA
hPDI  a  DAPEEEDHVLVL-RKSNFAEALAAH--KYLLVEFYA
                  150       160          170
hPDI  b  DVE-----SDSAKQFLQAAEAI----DDIPFGITS- 
hTRX    T--WCGPCKMIKPFFHSLSEKY----SNVIFLEVDV
hPDI  a  P--WCGHCKALAPEYAKAAGKLKAEGSEIRLAKVDA
  
                  180        190          200 
            *               *              *
hPDI  b  --NSDVFSKYQLDKD-GVVLFKKFDEG--RNNF-EG   
hTRX    DDCQDVASECEVKCMPTFQFFKKGQ---KVGEF-SG
hPDI  a  TEESDLAQQYGVRGYPTIKFFRNGDTASPKEYTA-G
                210       220
hPDI  b  EVTKENLLDFIKHNQLPLVIEFTEQTA
hTRX    ANK-EKLEATINELV------------ 
hPDI  a  REA-DDIVNWLKKRTGPAA--------
Function of the b and b¢ domains
Addition of the b and b′ modules to the a or a′ modules
gradually increases the disulfide isomerase activity of PDI
(our unpublished observations). This is likely to result
from the binding of the b and b′ modules to substrate pro-
teins, because many thioredoxins have well-characterized
peptide-binding sites [22–24]. The multiple thioredoxin
modules of PDI may provide multiple sites of contact with
substrate proteins. As PDI has also been identified as the
b subunit of prolyl 4-hydroxylase [25] and as one of the
two subunits of the microsomal triglyceride transfer
protein complex [26], the various PDI modules may also
be involved in these additional activities.
The b and b′ modules appear to have lost the thioredoxin
function of catalyzing thiol-disulfide exchange reactions
(they have no detectable activity; our unpublished obser-
vations). Neither module contains the two cysteine
residues that are normally found at the active site of
thioredoxin, and, in fact, the active site appears to have
been deleted from the b domain (Fig. 5). Other residues
that normally contribute to the catalytic activity of thiore-
doxin, such as Asp26, Trp31 and Pro75 of human thiore-
doxin, which are conserved in the a and a′ modules, have
all been replaced in the b and b′ modules. On the other
hand, the thioredoxin-like modules of PDI have not incor-
porated any substantial insertions like those that have
occurred in other members of the family of thioredoxin-
related molecules, some of which have extra domains of
up to 76 residues inserted at surface positions within the
thioredoxin motif [6].
The thioredoxin motif has clearly been adapted
considerably in the PDI b and b′ modules. Examples of less
extreme functional adaptations are known in PDI homo-
logues in which segments with detectable homology to
thioredoxin have lost one of the two active-site cysteine
residues [27]. The enzyme glutathione peroxidase has a
thioredoxin motif, but the accessible cysteine residue has
been changed to a selenocysteine, and the second cysteine
residue has been replaced with threonine [28]. Glutathione
S-transferase also has a thioredoxin motif, but with no cys-
teine-type residues at its active site; nevertheless, this
enzyme binds to the cysteine residue of its substrate, glu-
tathione, at a position corresponding to the accessible cys-
teine of thioredoxin [29]. Thus, the absence of cysteine
residues does not rule out the possibility that the b or b′
modules may act on thiol and disulfide groups, although no
such activities have been detected so far. The PDI b
module also has significant homology to the calcium-
binding protein calsequestrin [13], which would appear to
be an extreme adaptation of the thioredoxin fold.
Conclusions
The folds of two domains of PDI have now been
determined experimentally. As expected on the basis of
sequence homology, the PDI a domain, which includes the
–Cys–Gly–His–Cys– active-site sequence, adopts a fold
very similar to that of thioredoxin [15]. Despite the absence
of any significant sequence similarity to the a domain or to
thioredoxin, the ‘non-catalytic’ PDI b domain also adopts
the same fold. The structures of the other two PDI domains
— the a′ and b′ domains — have yet to be solved. The PDI
a′ domain is obviously an internal repeat of the a domain
(because they share 47% sequence identity) and will almost
certainly have the same fold. The degree of sequence iden-
tity between the b and b′ domains is not sufficiently exten-
sive to be certain that they are internal repeats, but,
nevertheless, there are indications that the b′ domain adopts
a thioredoxin-like fold. The a and a′ domains of PDI
contain the active site and can catalyze a subset of reactions
catalyzed by intact PDI [10,16]. However, the non-catalytic
b and b′ domains appear to be important for the disulfide
rearrangement activity of PDI, and possibly also its other
enzymatic roles. These properties cannot be attributed
simply to single domains, but most probably involve an
interplay between the different thioredoxin-like modules of
PDI. Structural studies of all of the PDI modules and of
multi-domain constructs will be essential in order to explain
the full spectrum of PDI activities.
Materials and methods
Materials and sample preparation
The b domain (residues 119–228) of human PDI was prepared as
described previously [13]. The methods to produce the [15N]- and [15N
plus 13C]-labelled forms were similar to those used previously for the
PDI a domain [15,30]. The proteins were dissolved to concentrations
of 1–2 mM in 93% 1H2O/7% 2H2O (v/v) containing 10 mM sodium
phosphate buffer at pH 6.5.
NMR spectroscopy
All NMR spectra were recorded at 300 K on a Varian Unity INOVA 600
spectrometer, except for the 15N-resolved three-dimensional NOESY
experiment, which was recorded on a Bruker AMX600 spectrometer.
Both spectrometers were equipped with triple-resonance z-gradient
probes. The 1H, 13Ca, and 15N backbone resonances of the PDI b
domain were assigned from CBCANH, CBCA(CO)NH, and
HBHA(CBCACO)NH triple-resonance experiments [31,32]. Assign-
ment of the sidechains also used HC(C)H-TOCSY and H(C)CH-
COSY experiments [33,34].
Collection of structural data
A total of 850 intraresidue and interresidue proton–proton NOEs
(Table 1) were obtained from the analysis of 13C- and 15N-separated
three-dimensional NOESY experiments recorded with a mixing time of
100 ms. Vicinal 3JHNHa-coupling constants were measured using a
three-dimensional HNHA experiment [35]. A number of first sidechain
dihedral angles x1, together with b-methylene proton stereospecific
assignments, were determined by estimation of 3JHaHb- and 3JNHb-
coupling constants, using a three-dimensional 15N-TOCSY-HSQC
experiment recorded with a short coherence mixing time (30 ms) [36],
and a three-dimensional HNHB experiment [37], respectively.
Structure calculations
Structures of the polypeptide backbone were calculated using X-PLOR
[38]. Distance restraints were classified according to their observed
intensities in the NOESY spectra as strong (0.18–0.25 nm), medium
(0.18–0.35 nm) or weak (0.18–0.50 nm). The calculations were based
on a total of 850 proton–proton distance restraints, of which 324 were
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intraresidue, 307 sequential, 103 between residues separated in the
sequence by 1–3 residues, 103 more than 3 residues apart, and 13
ambiguous (Table 1). In the calculations, 52 f dihedral angle restraints
were used. The angle f was restrained to –60 (± 30)° if 3JHNHa < 5 Hz
or to –120 (± 30)° if 3JHNHa > 8 Hz. Depending on the relative values of
3JHaHb and 3JNHb (see above), 23 x1 dihedral angles were restrained to
–60 ( ±30)°, 60 ( ±30)° or 180 ( ±30)°. First, 50 structures were gen-
erated using a hybrid distance-geometry/simulated-annealing approach
[39]. Subsequently, from this initial set, 20 structures with the lowest
total energy were selected for further rounds of refinement using simu-
lated annealing. Finally, an ensemble of the 10 structures with the
lowest total energy was used for structural analysis. The coordinates of
the final 10 structures representing the PDI b domain will be made
available on the World Wide Web server of the European Molecular
Biology Laboratory (URL http://www.nmr.embl-heidelberg.de).
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